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Toxicological mass casualty event
a  b  s  t  r  a  c  t
Objective:  Exposure  to organophosphates  (OP)  may  lead  to a life  threatening  cholinergic  cri-
sis with  death  attributed  to  a  rapidly  progressive  respiratory  failure.  In a  toxicological  mass
casualty event  involving  organophosphate  exposure,  many  of  the  victims  may  depend  on
immediate  short-term  ventilation  to overcome  the  respiratory  distress  which  may  exhaust
life supporting  resources.  In addition,  the mandatory  use  of personal  protective  gear by
ﬁrst responders  emphasizes  the need  for a noninvasive,  easy-to-operate  ventilation  device.
Our objective  was  to  assess  the efﬁcacy  of  MRTX,  a Biphasic  Cuirass  Ventilation  device,  in
comparison  with  standard  bag-valve  mask  ventilation  following  acute  organophosphate
poisoning.
Methods:  Pigs  were  exposed  to  paraoxon  poisoning  (1.4 LD50),  and  treated  8 min  later  with
atropine  (0.05  mg/kg).  The  control  group  received  no  further  support  (n  =  9),  the  two  exper-
imental groups  received  ventilation  support  initiated  15 min  post  exposure  and  lasted  for
25 min:  one  group  was  ventilated  with  the  commonly  used  bag-valve  mask  (Mask  group,
n =  7) and the  other  was  ventilated  with  the  Biphasic  Cuirass  Ventilation  device  (Cuirass
group,  n =  7).  Clinical  signs  and  physiological  parameters  were  monitored  during  the  ﬁrst
hour, and  mortality  up  to 24  h  post  exposure  was  recorded.
Results: No mortality  was  observed  in  the  Cuirass  group  following  OP poisoning,  while
mortality  in  the  Control  and  in  the  Mask  groups  was  high  (67%  and  71%,  respectively).
Mouth  excretions  of the  cuirass-ventilated  animals  were  frothy  white  as  in  deep  suctioning,
as opposed  to the  clear saliva-like  appearance  of secretions  in the  other  two  groups.  No
further  group  differences  were  recorded.
Conclusions:  The  noninvasive,  easy-to-operate  Biphasic  Cuirass  Ventilation  device  was
effective  in  reducing  OP-induced  mortality  and  might  be  advantageous  in  an  organophos-
phate  mass  casualty  event.  This  ﬁnding  should  be validated  in  further  investigations.
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. Introduction
Exposure to organophosphates (OP) results in a cholin-
rgic crisis manifested as a dose dependent hypersecretion,
asciculation, tremor, convulsions, coma, respiratory fail-
re and death [1–7]. Immediate treatment with an
nticholinergic drug such as atropine sulfate and an oxime
ounteract some of the poisonous effects [6,8]. To amelio-
ate OP-induced centrally mediated seizure activity that
an progress to status epilepticus and result in perma-
ent brain damage, an anti-convulsing drug is also required
9–13]. The immediate cause of death following OP poison-
ng is a rapidly progressive respiratory failure caused by a
omplex pathophysiology, characterized by bronchocon-
triction, profuse salivation, bronchorrhoea, respiratory
uscle paralysis, and depression of the respiratory centers
n the brain [14–17].
In an OP toxicological mass casualty event, be it an acci-
ent or a terrorist attack, several challenges are expected
o impact casualty management, including a shortage of
rained medical personnel, difﬁculties in performing intu-
ations due to excess salivation, bronchoconstriction and
onvulsions, operator inexperience, poor patient position-
ng (often on ﬂoor), and limitations imposed by wearing the
umbersome personal protective gear [3,18]. Under these
ircumstances, a lightweight, easy to operate, portable and
on-invasive ventilator could be highly advantageous.
The MRTX is a Biphasic Cuirass Ventilation device
Fig. 1a) that provides a non-invasive support based on
 light cuirass tightly ﬁt around the patient’s chest. The
RTX is simple to operate, even while wearing personal
rotective gear [19,20], it can be used within seconds
y minimally trained personnel and, if needed, on fully
ressed casualty. It is a portable device and operates using
echargeable batteries. The device is unique in that it con-
rols not only inspiration but expiration as well, which is of
ritical importance when having bronchoconstriction and
aralysis as in OP poisoning.
The aim of the present study was to compare the Cuirass
entilation technique with the commonly used bag-valve
ask ventilation device in terms of survival and clinical
core, in a well-established pig model of OP poisoning.
ag-valve mask ventilation is a positive pressure ventila-
ion technique expected to be widely used on-scene in an
P mass casualty event. The pig model used here exhibits
rolonged respiratory distress following exposure to the
rganophosphate paraoxon. The model enabled the study
f the beneﬁcial effects of ventilation support following OP




The study was approved by the IIBR Animal Ethics
ommittee, according to the recommendations of the
uide for the Care and Use of Laboratory Animals, National
cademy Press, Washington DC, 1996. White domes-
ic female pigs (Laboratory animals farm, Lahav, Israel),Fig. 1. (a) The MRTX device. The cuirass (b) and mask (c) were specially
designed for pigs.
weighing 18–20 kg were used for this study, following 2–3
days of acclimatization in the animal facility.
Animals were housed individually in a temperature
(21 ± 2 ◦C) and humidity (50 ± 10%) controlled animal
quarters, and maintained on 12 h light–dark cycles (light
on at 0600 am).
2.2. Materials and devices
Paraoxon and atropine sulphate (Sigma chemicals,
Israel) and propofol 1% (Taro Pharmaceutical Industries Ltd,
Israel) were used. ECG, heart rate and O2 saturation recor-
dings were performed using AcqKnowledge Software and
Biopac Hardware Facility (Biopac Systems Inc., USA). The
saturation probe was placed on the animals’ tails, with reli-
ableand consistent readings throughout the study. Arterial
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pO2, arterial pCO2, arterial pH and base excess (BE) were
analyzed using the Osmotech OPTI CCA Blood Gas Ana-
lyzer (Osmotech Incorporated, USA). An MRTX ventilator
(MediVent International LTD, UK) was used with a cuirass
specially designed and manufactured by the company to ﬁt
the chest wall of a pig (Fig. 1a and b).
2.3. Study design and setting
2.3.1. Preliminary study
Pigs were restrained on a speciﬁcally designed appa-
ratus throughout the experiment. The adjustment of the
two ventilation devices and the feasibility of their use were
tested on two pigs anesthetized with Propofol (3.5 mg/kg,
iv). One animal was ventilated by a standard bag-valve
device with a specially-designed face-mask and with
no intubation (Fig. 1c). The bag-valve mask device was
adjusted to the animal’s snout in order to establish a good
seal. This was important in order to prevent delivery of
high tidal volumes which may  lead to high intrathoracic
pressures and cardiovascular collapse and possible baro-
trauma. The bag-valve device did not have a pressure limit
valve. We  used a 1 l bag size. The MRTX with its cuirass
was set on −25 negative and +5 positive pressures. Inspira-
tory: expiratory ratio was set on 1:1, based on prior clinical
experience (this causes less atelectasis). Although we did
not expose the pigs to OP in this preliminary study, we fol-
lowed local clinical recommendations for the treatment of
OP casualties, which includes hyperventilation, to reduce
OP-induced hypercapnia. In both cases respiratory rate was
kept on 30 breaths per minute, and ventilation lasted for
25 min, with no oxygen supplementation.
Both devices were effective in ventilating the animals.
Physiological parameters were monitored continuously
and no signiﬁcant changes were observed. Vital signs
included heart rate derived from ECG, O2 saturation by
pulse-oximetry placed on the animals’ tails, non-invasive
blood pressure and EtCO2. Ventilation was monitored by
watching chest wall movement and blood saturation.
2.3.2. Main study
Restrained pigs were ﬁtted with an intravenous line and
anesthetized using Propofol (3.5 mg/kg, iv) to enable the
insertion of an arterial cannula into the pigs’ ear. About
40 min  later, when the pig regained full neck muscle tone,
exposure to paraoxon was performed. An intramuscular
dose of 600 g/kg paraoxon (the equivalent of 1.4 LD50)
was followed 8 min  later by a single administration of
atropine (0.05 mg/kg, i.m.) alone, to simulate a realistic
scenario, in which severe respiratory distress is likely to
develop [21].
Following the paraoxon exposure three possible treat-
ments were evaluated: Ventilation support using the
biphasic cuirass device (Cuirass group, n = 7), ventila-
tion support using a bag-valve mask (Mask group, n = 7)
and a control group that received no ventilation sup-
port (Control, n = 9). No oxygen enrichment was provided
(FiO2 = 0.21). Ventilation was initiated 15 min  following
exposure and regardless of clinical manifestations was  ter-
minated 25 min  later.rts 2 (2015) 40–45
Rate of ventilation was  kept at 30 breaths per minute
in both groups, with the same MRTX settings as in the
preliminary study.
Animals were closely observed for chest wall movement
and post exposure signs. The following parameters were
monitored continuously for 1 h after paraoxon exposure:
ECG, Heart rate (derived from ECG), O2 saturation by pulse-
oximetry placed on the animals’ tails, and blood pressure
by using an arterial line placed in the animals’ ear. Arte-
rial blood gases (arterial pO2, arterial pCO2, arterial pH and
BE) were collected from the arterial line before poisoning
(0′) and 10, 20, 30, 40, and 50 min  following exposure. The
following clinical signs were recorded every 10 min  during
the ﬁrst hour post exposure and 24 h later: fasciculation,
salivation, teeth clenching, tremor, dermal patches, con-
vulsion, and respiratory distress. The score ranged from 0
(no effect) to 3 (severe effect). Time of death within the 24 h
was  also recorded.
All animals were allowed to recover with no further
help, for a period of 24 h. After 24 h all animals were
euthanized using i.v. overdose of sodium pentobarbital
(200 mg/ml).
2.4. Statistical analysis
The physiological data is presented as mean ± SE. Sur-
vival is presented as percentage and the differences were
analyzed using the non-parametric Kaplan–Meier analysis
(SPSS® computer program version 22, IBM).
3. Results
3.1. Clinical observations
Typical OP-induced symptoms were seen follow-
ing exposure to paraoxon. Fasciculation, tremor, teeth
clenching and salivation appeared within 5–10 min  after
paraoxon injection, followed by respiratory distress and
tonic–clonic convulsions. All animals showed signs of sig-
niﬁcant respiratory distress within 15 min  of exposure,
manifested as tachypnea, cyanosis and gasping. If no ven-
tilation support was  provided, the clinical condition of the
animals deteriorated rapidly and most of the animals died
within 1 h of exposure (Control group: 67%, 6 out of 9 died
within 24 h). In the bag-valve Mask group, the animals
survived the 25 min  of ventilation, but shortly after ven-
tilation was  terminated, the mortality rate resembled that
of the control group (Mask group: 71%, 5/7). In contrast,
no mortality was  recorded following 25 min  ventilation
with the cuirass, and the pigs recovered better and faster
(Cuirass group: 0%, 0/7). Survival analysis (Kaplan–Meier,
Fig. 2) showed signiﬁcant differences between groups
(2(2) = 8.32, p < 0.016), and pairwise comparison showed
no differences between Control and Mask but both groups
differ from the Cuirass group (p < 0.009).
A key observation relates to oropharyngeal secretions:
Mouth excretions of the cuirass-ventilated animals were
frothy white as in deep suctioning, as opposed to the
clear saliva-like appearance of secretions in the other two
groups. No other clinical differences between the bag-
valve group and the Cuirass group, and no changes in







































eig. 2. Kaplan–Meier plot of mortality of the three groups. Time “0”
epicts the beginning of ventilation in the Mask and the Cuirass groups.
entilation lasted for 25 min.
emodynamic parameters were observed (see below). In
urviving animals, no signiﬁcant differences were found
etween the three groups in any of the clinical signs
bserved (data not shown). 24 h following paraoxon expo-
ure, most surviving pigs still showed ataxia, tremors at
xertion and low mobility. At that time, 3 of the Cuirass
roup, and 1 of the surviving Mask group showed minor to
o toxicity signs.
.2. Physiological parameters
Pre-exposure mean values of the physiological param-
ters were within normal limits for all three study groups
data not shown).
Following exposure to paraoxon all three groups exhib-
ted 30% reduction in hemoglobin saturation together with
n increase in arterial pCO2 and a decrease in arterial pO2,
ompared to baseline. Reduction in both BE and blood pH
ere found in all three groups studied (an average decrease
n BE of 15.3 ± 1.6 mEq/l in the Cuirass group, 16.3 ± 2.7
n the Mask group, and an average reduction of pH from
.5 to 7.14 in the Cuirass and Mask groups, respectively).
inus bradycardia (30–35% decrease) peaked at 20–30 min
ost exposure (113 ± 11 bpm in the Cuirass group) and
as slightly lower in the Control and the Mask groups
95 ± 9 bpm).
. Discussion
In OP poisoning, the immediate respiratory failure is
ostly due to central respiratory mechanisms, with sec-
ndary effects of high dynamic airﬂow obstruction from
ecretions and bronchoconstriction, as well as from ﬂac-
id paralysis [22,23]. The pig model of paraoxon poisoning
sed here exhibited reproducible prolonged respiratory
istress and delayed mortality, with signs and symptoms
haracteristic of organophosphate poisoning [21].
The most important ﬁnding in the present study was
he dramatic effect of Cuirass technique in reducing the
araoxon-induced mortality (Fig. 2). This Cuirass technique
as found to be superior to bag-valve mask ventilation, a
ommon ventilation procedure, expected to be used fol-
owing both single exposure and on-scene mass casualty
vent.rts 2 (2015) 40–45 43
Earlier studies have demonstrated that respiratory fail-
ure was the predominant cause of death in nerve agent
poisoning and that signiﬁcant cardiovascular depression
occurred only after cessation of respiration [24,25]. This
emphasizes the importance of respiratory support over
cardiovascular support during early stages following OP
poisoning.
Biphasic Cuirass Ventilation has been reported as an
easily-adopted and rapidly-applied method suitable for use
by non-medical personnel, even while wearing protective
gear [20]. In addition, Ben-Abraham et al. [19] have indi-
cated that physicians wearing full personal protective gear
applied the cuirass and instituted ventilation faster than
performing endotracheal intubation followed by positive
pressure ventilation.
Unfortunately, as we  have shown here for the ﬁrst time,
the bag-valve mask ventilation did not sufﬁciently improve
the impact of OP exposure unless continuously imple-
mented. While animals survived during ventilation, shortly
after its termination the animals died and mortality rates
resembled that of the non-ventilated Control group. In con-
trast, ventilation with the cuirass for the same period of
time prevented 24 h mortality and the animals recovered
better and faster with no deterioration following cessation
of ventilation.
An additional advantage of the Cuirass relates to air-
way management. In pre-hospital ventilation, a jaw thrust
into the BVM is required to avoid the tongue occluding the
airway, assuming the supine position of the casualty. This
adds to the difﬁculties of using BVM in the pre-hospital set-
ting of a chemical event. When using the cuirass there is no
need for a jaw thrust, as the use of a guedel is enough. In our
study there was  no need for that since the animals were in
a prone position.
In recent years several studies described a successful use
of supraglottic airways and intubation in the pre-hospital
setting [26–29]. Endotracheal intubation is still regarded as
the golden standard, and supraglottic airways are regarded
a bridge until deﬁnite airway control is achieved [30]. When
looking at the success rates, supraglottic airways are easier
to manage, including in a chemical event [26–30]. However,
since supraglottic airways will be still connected to a bag-
valve device, the results may  be similar to that described in
the present study. Other limitations of supraglottic airways
in a chemical event is the difﬁculties in performing suction,
it does not prevent aspirations, and high-pressure ventila-
tion which is important in preventing acute lung injury is
not possible [30].
Several observations should be highlighted:
1. In the present study, the excretions of the cuirass-
ventilated animals were frothy white, similar to that
seen after deep suctioning. In the Control and Mask
groups, secretions were clear, saliva-like in appearance.
In a study testing the use of Biphasic Cuirass Ventila-
tion in OP-exposed cats, the device enabled clearance
of bronchial secretions, saving the need for active suc-
tioning of the airways [31]. The use of bag-valve mask
ventilation requires further support against airway con-
striction combined with the vast secretions following
ogy Repo
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OP poisoning. Active suction of these secretions is an
important supportive measure [7].
2. A major aspect of acute lung injury is the regulation
of alveolar ﬂuid clearance. Under normal conditions,
molecular and cellular mechanisms regulate the active
transport of solutes and ﬂuids across the alveolar epithe-
lium, thus enabling optimal gas exchange [32–34]. In OP
poisoning as is with other pathologies involving respi-
ratory failure and non-cardiogenic pulmonary edema,
ﬂooding of the alveolar air spaces with proteinaceous
ﬂuid which the epithelium cannot rapidly remove is
evident [33,35–37]. This represents a pathological pro-
cess of a failure to maintain proper airway ﬂuid balance.
Furthermore, exposure of the alveolar epithelium to
hypoxic conditions has signiﬁcant adverse effects on
epithelial function [34]. We  hypothesize that cuirass use
improved alveolar ﬂuid clearance and by doing so, may
have preserved its critical role in attenuating the devel-
opment of acute lung injury. This hypothesis deserves
further study since lung secretions and lung tissues were
not analyzed in this study.
3. The use of the cuirass may  help in preventing recurrent
alveolar collapse and reopening, and in achieving alveo-
lar recruitment, by reducing tidal volumes and applying
positive end-expiratory pressure [38–40]. It is generally
thought that the use of positive pressure ventilation may
cause further harm due to over-distention with baro-
trauma, as may  be the case in bag-valve mask ventilation
[38,41–43]. Failure in opening all atelectatic areas using
the bag-valve mask technique may  even contribute to
the OP-induced damage. The cuirass technique, which
better resembles the physiological way of ventilation,
avoids this problem [44].
4. Most OP studies in animals focus on pharmacologi-
cal interventions for the primary goal of preventing
immediate death. Only few of them were dedicated
to pre-hospital respiratory support (e.g. [45]). Because
of the acute nature of OP poisoning and the relatively
good response to the antidotes, ventilatory support is
required immediately and for a relatively short period
of time [46]. In light of the present results, the meth-
ods of ventilation following various OP nerve agents
exposure should be further evaluated, in addition to
the available antidotal treatment. It should be noted
that exposure to other chemical agents such as phos-
gene, may  result in acute respiratory distress syndrome
(ARDS) that will require longer ventilation times [47]. In
the current study we compared the cuirass to bag-valve
mask ventilation only, since it is the more common mode
of ventilation on-site. Although the use of an endotra-
cheal intubation may  improve success rate of bag-valve
ventilation, the need for sedation and skilled personnel
impede its use in mass casualty event and hence was  not
included in our study.
5. The cuirass technique was previously shown to have
beneﬁcial effects on the cardiovascular system too,
i.e. decreasing intra-thoracic pressures and increasing
venous return and cardiac output [44,48,49]. In these
studies, the cuirass technique offered ventilation sup-
port similar to that of positive pressure ventilation,
with the addition of improved cardiac output. Acute
[rts 2 (2015) 40–45
cardiovascular effects following OP poisoning appear
only after respiratory failure is already apparent [24,25].
We did not observe signiﬁcant differences in both
respiratory and cardiovascular parameters between the
experimental groups in the present study. Thus, the ben-
eﬁt of the cuirass technique is unlikely to be attributed
to cardiovascular effects. However, we did not measure
cardiac output in our study.
5. Conclusions
The current study demonstrates the efﬁcacy of the
cuirass device in severe respiratory distress induced by
paraoxon exposure in a pig model. The minimal antidotal
treatment applied here was sufﬁcient to ensure 24 h sur-
vival if the cuirass technique was implemented. Without
this cuirass ventilation high mortality rate was  seen.
We conclude that the MRTX, a noninvasive, easy-
to-operate Biphasic Cuirass Ventilation device might be
advantageous on-scene in an OP mass casualty event. This
ﬁnding should be validated in further investigations.
Transparency document
The Transparency document associated with this article
can be found in the online version.
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